{"database": "lobbying", "table": "lobbying_activities", "rows": [[1439633, "5ecc2361-5e02-48f3-987b-db56f256cb07", "Q3", "MCDERMOTT WILL & SCHULTE LLP", 24338, "ALLERGAN, INC.", 2013, "third_quarter", "PHA", "Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation", "Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2013-10-09T15:13:28.940000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1439633"], "units": {}, "query_ms": 19.97910300269723, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}